Actively Recruiting
Using Sequencing to Predict Outcomes in Ventilator-Associated Lower Respiratory Tract Infections A Multi-center Study of Early Microbiological Response and Patient Recovery
Led by The First Affiliated Hospital with Nanjing Medical University · Updated on 2025-05-23
200
Participants Needed
1
Research Sites
4 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are studying ventilator-associated lower respiratory tract infections, focusing on how changes in local pathogen levels relate to patient outcomes. They are evaluating a tool called QtNGS that measures these pathogens using advanced sequencing techniques. This multi-center prospective study aims to better understand the connection between pathogen abundance before and after treatment and how it affects recovery or complications. Participants will have bronchoscopy procedures to collect lung fluid samples at enrollment and three days after treatment. These samples will help measure pathogen levels using the QtNGS tool. The study does not involve experimental treatments but observes patients who have been on mechanical ventilation and have signs of infection. During the study, participants will undergo bronchoscopy at two time points to collect fluid for analysis. Researchers will track clinical outcomes including mortality within 28 days after enrollment. The study involves careful monitoring of infections by specific bacteria and collects data to assess the relationship between early microbiological changes and patient prognosis over about one month.
CONDITIONS
Brief Title
Predicting Ventilator-associated Lower Respiratory Tract Infection Outcomes Using Sequenced-based Early Microbiological Response
Research Team
W
Wenkui Sun, Dr
J
Ji Zhou, Dr
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here